Breast cancer: From the research

In this video, we go behind the scenes and look at breast cancer research. As mentioned in previous videos, the HER2-positive subtype is more complicated to treat because some patients do not respond to therapy. Dr Rosemarie Marchan is a scientist at IfADo and leads a research group that focuses on metabolic processes. She researches the enzyme EDI3 in the context of breast and ovarian cancer.
Content:
0:20 The role of EDI3 in breast cancer
3:21 The discovery of EDI3
4:39 The inhibitor and regulation of EDI3
7:16 The next steps in research on EDI3